HONG KONG – It is a tumultuous year for Korean conglomerate Samsung, whose group chief Jay Y. Lee was arrested Friday in connection to a corruption scandal, and Samsung Biologics Co. Ltd., the company's contract manufacturer arm of biologic drugs, coming under scrutiny with allegations of being involved in unlawful accounting practices.
